The Second Affiliated Hospital of Wenzhou Medical University
The Second Affiliated Hospital of Wenzhou Medical University
Wenzhou, China13 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TrIal of Early Minimally Invasive Catheter Evacuation With Thrombolysis in IntraCerebral Hemorrhage | Hemorrhage, Intracranial Hemorrhages, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, intracerebral hemorrhage, nervous system disorder, vascular disorder | Recruiting | Not applicable | 2026-09-09 | NCT07187687 | |
| Early Lumbar Drainage for Intraventricular Hemorrhage | Hemorrhage, Intracranial Hemorrhages, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, intracerebral hemorrhage, nervous system disorder, vascular disorder | Not yet recruiting | Not applicable | 2026-09-04 | NCT07625449 | |
| Non-stenting Treatment Strategy for Acute Myocardial Infarction With Non-severe Stenosis(EROSION IV) | Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, ST-elevation myocardial infarction, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorder | Recruiting | Not applicable | 2026-07-16 | NCT07567625 | |
| A Phase Ib/IIa Study of INT-210 Capsules in Participants With Active Ulcerative Colitis | Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Recruiting | Phase 1 / Phase 2 | 2026-07-09 | NCT07692165 | |
| 24-Week Recurrence Rate of Gout Following Firsekibart Treatment | Gout Flare | Not yet recruiting | Not applicable | 2026-06-04 | NCT07625514 | |
| Efficacy and Safety of Scheduled Versus As-Needed Firsekibart Administration for the Prevention of Gout Recurrence: A Multicenter, Open-Label, Randomized Controlled Trial | Gout Flares | Not yet recruiting | Not applicable | 2026-06-01 | NCT07616531 | |
| The Efficacy and Safety of Inpegsomatropin Injection in Children With Short Stature Born Small for Gestational Age | Small for Gestational Age | Recruiting | Phase 3 | 2026-05-08 | NCT07309562 | |
| Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture | Bone Diseases, Metabolic, Nutritional and Metabolic Diseases, Osteoporotic Fractures, bone disorder, bone fracture, injury, metabolic disease, musculoskeletal system disorder, osteoporosis | Recruiting | Not applicable | 2026-01-12 | NCT05866029 | |
| Stereotactic Aspiration of Brain Stem Hematoma | Brain Stem Hematoma | Not yet recruiting | Not applicable | 2025-12-30 | NCT07300501 | |
| Real-world Study on Liver Cancer Risk in Chronic Hepatitis B Patients With Family History of Liver Cancer | hepatocellular carcinoma | Not yet recruiting | Not stated | 2025-06-05 | NCT07007286 | |
| Efficacy and Safety of a Half-dose Bolus of r-SAK Prior to Primary PCI in ST-elevation Myocardial Infarction | Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, ST-elevation myocardial infarction, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorder | Recruiting | Phase 4 | 2024-10-28 | NCT05410925 | |
| Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease（OCEAN PROJECT） | Blood-Borne Infections, Chronic Disease, DNA Virus Infections, Digestive System Diseases, Disease Attributes, Hepadnaviridae infectious disease, Hepatitis, Chronic, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic hepatitis B virus infection, fatty liver disease, hepatitis, hepatitis B virus infection, infectious disease, liver disorder, metabolic dysfunction-associated steatotic liver disease, viral hepatitis, viral infectious disease | Recruiting | Phase 4 | 2024-04-16 | NCT06368882 | |
| Angiography-Derived FFR And IVUS for Clinical Outcomes in Patients With Coronary Artery Disease | Arterial Occlusive Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorder | Active, not recruiting | Not applicable | 2024-01-23 | NCT04397211 |